432137646	432137646	CD	B-NP	O
|	|	NN	I-NP	O
LH	LH	NN	I-NP	O
|	|	NN	I-NP	O
15354529	15354529	CD	I-NP	O
|	|	NN	I-NP	O
|	|	NN	I-NP	O
721939	721939	CD	B-NP	O
|	|	CC	I-NP	O
10/17/2001	10/17/2001	CD	I-NP	O
12	12	CD	I-NP	O
:	:	:	O	O
00	00	CD	B-NP	O
:	:	:	O	O
00	00	CD	B-NP	O
AM	AM	VBP	B-VP	O
|	|	JJ	B-NP	O
afib	afib	NN	I-NP	O
,	,	,	O	O
S/P	S/P	NN	B-NP	B-protein
TIA	TIA	NN	I-NP	I-protein
|	|	NN	I-NP	I-protein
|	|	NNP	I-NP	O
DIS	DIS	NNP	I-NP	O
|	|	NNP	I-NP	O
Admission	Admission	NNP	I-NP	O
Date	Date	NNP	I-NP	O
:	:	:	O	O
3/16/2001	3/16/2001	CD	B-NP	O
Report	Report	NNP	I-NP	O
Status	Status	NNP	I-NP	O
:	:	:	O	O
Discharge	Discharge	NNP	B-NP	O
Date	Date	NNP	I-NP	O
:	:	:	O	O
7/23/2001	7/23/2001	CD	B-NP	O
******	******	SYM	I-NP	O
DISCHARGE	DISCHARGE	NN	I-NP	O
ORDERS	ORDERS	NN	I-NP	O
******	******	SYM	B-VP	O
MONRO	MONRO	NN	B-NP	O
,	,	,	O	O
BOBBIE	BOBBIE	NN	B-NP	O
474-06-60-5	474-06-60-5	CD	I-NP	O
Ponce	Ponce	NNP	I-NP	O
Service	Service	NNP	I-NP	O
:	:	:	O	O
CAR	CAR	NN	B-NP	O
DISCHARGE	DISCHARGE	NN	I-NP	O
PATIENT	PATIENT	NN	I-NP	O
ON	ON	NN	I-NP	O
:	:	:	O	O
6/5/01	6/5/01	CD	B-NP	O
AT	AT	NN	I-NP	O
05	05	CD	I-NP	O
:	:	:	O	O
00	00	CD	B-NP	O
PM	PM	NNP	I-NP	O
CONTINGENT	CONTINGENT	NNP	I-NP	O
UPON	UPON	NNP	I-NP	O
Home	Home	NNP	I-NP	O
services	service	NNS	I-NP	O
WILL	WILL	NNP	I-NP	O
D/C	D/C	NNP	I-NP	O
ORDER	ORDER	NNP	I-NP	O
BE	BE	NNP	I-NP	O
USED	USED	NNP	I-NP	O
AS	AS	NNP	I-NP	O
THE	THE	NNP	I-NP	O
D/C	D/C	NNP	I-NP	O
SUMMARY	SUMMARY	NNP	I-NP	O
:	:	:	O	O
YES	YES	NNP	B-NP	O
Attending	Attending	NNP	I-NP	O
:	:	:	O	O
ZUBRZYCKI	ZUBRZYCKI	NNP	B-NP	O
,	,	,	O	O
FIDEL	FIDEL	NNP	B-NP	O
JAMEL	JAMEL	NNP	I-NP	O
,	,	,	O	O
M.D.	M.D.	NNP	B-NP	O
,	,	,	O	O
PH.D.	PH.D.	NNP	B-NP	O
.	.	.	O	O

CODE	CODE	NN	B-NP	O
STATUS	STATUS	NNS	I-NP	O
:	:	:	O	O
Full	Full	JJ	B-NP	O
code	code	NN	I-NP	O
DISPOSITION	DISPOSITION	NN	I-NP	O
:	:	:	O	O
Home	Home	NN	B-NP	O
w	w	NN	I-NP	O
/	/	SYM	B-NP	O
services	service	NNS	I-NP	O
DISCHARGE	DISCHARGE	NN	I-NP	O
MEDICATIONS	MEDICATIONS	NNS	I-NP	O
:	:	:	O	O
DIGOXIN	DIGOXIN	NN	B-NP	B-DNA
0.125	0.125	CD	I-NP	I-DNA
MG	MG	NN	I-NP	I-DNA
PO	PO	NN	I-NP	I-DNA
QD	QD	NN	I-NP	I-DNA
PROZAC	PROZAC	NN	I-NP	I-DNA
-LRB-	-LRB-	NN	I-NP	I-DNA
FLUOXETINE	FLUOXETINE	NN	I-NP	I-DNA
HCL	HCL	NN	I-NP	I-DNA
-RRB-	-RRB-	,	O	I-DNA
40	40	CD	B-NP	I-DNA
MG	MG	NNP	I-NP	I-DNA
PO	PO	NNP	I-NP	I-DNA
QD	QD	NNP	I-NP	I-DNA
COUMADIN	COUMADIN	NNP	I-NP	I-DNA
-LRB-	-LRB-	NNP	I-NP	I-DNA
WARFARIN	WARFARIN	NNP	I-NP	I-DNA
SODIUM	SODIUM	NNP	I-NP	I-DNA
-RRB-	-RRB-	NNP	I-NP	I-DNA
5	5	CD	I-NP	I-DNA
MG	MG	NNP	I-NP	I-DNA
PO	PO	NNP	I-NP	I-DNA
QHS	QHS	NNP	I-NP	I-DNA
Starting	Starting	NNP	I-NP	I-DNA
Today	Today	NNP	I-NP	I-DNA
-LRB-	-LRB-	NNP	I-NP	I-DNA
2/3	2/3	CD	I-NP	I-DNA
-RRB-	-RRB-	NNP	I-NP	I-DNA
Instructions	Instruction	NNPS	I-NP	I-DNA
:	:	:	O	O
or	or	CC	O	O
as	as	IN	B-SBAR	O
directed	direct	VBN	B-VP	O
by	by	IN	B-PP	O
doctor	doctor	NN	B-NP	O
Food/Drug	Food/Drug	NN	I-NP	O
Interaction	Interaction	NN	I-NP	O
Instruction	Instruction	NN	I-NP	O
No	No	DT	B-NP	O
high	high	JJ	I-NP	O
Vitamin-K	Vitamin-K	NN	I-NP	O
containing	contain	VBG	B-VP	O
foods	food	NNS	B-NP	O
Alert	Alert	NNP	B-NP	O
overridden	overridden	JJ	B-ADJP	O
:	:	:	O	O
Override	Override	NN	B-NP	O
added	add	VBN	B-VP	O
on	on	IN	B-PP	O
9/21/01	9/21/01	CD	B-NP	O
by	by	IN	B-PP	O
BETTINSON	BETTINSON	NNP	B-NP	O
,	,	,	O	O
VANCE	VANCE	NNP	B-NP	O
C.	C.	NNP	I-NP	O
,	,	,	O	O
M.D.	M.D.	NNP	B-NP	O
POTENTIALLY	POTENTIALLY	NNP	I-NP	O
SERIOUS	SERIOUS	NNP	I-NP	O
INTERACTION	INTERACTION	NNP	I-NP	O
:	:	:	O	O
ASPIRIN	ASPIRIN	NNP	B-NP	O
&	&	CC	I-NP	O
WARFARIN	WARFARIN	NNP	I-NP	O
Reason	Reason	NNP	I-NP	O
for	for	IN	B-PP	O
override	override	NN	B-NP	O
:	:	:	O	O
aware	aware	JJ	B-NP	O
LOVENOX	LOVENOX	NN	I-NP	O
-LRB-	-LRB-	NNP	I-NP	O
ENOXAPARIN	ENOXAPARIN	NNP	I-NP	O
-RRB-	-RRB-	NNP	I-NP	O
70	70	CD	I-NP	O
MG	MG	NNP	I-NP	O
SC	SC	NNP	I-NP	O
Q12H	Q12H	NNP	I-NP	O
Alert	Alert	NNP	I-NP	O
overridden	overridden	JJ	I-NP	O
:	:	:	O	O
Override	Override	NN	B-NP	O
added	add	VBN	B-VP	O
on	on	IN	B-PP	O
1/4/01	1/4/01	CD	B-NP	O
by	by	IN	B-PP	O
NAVE	NAVE	NNP	B-NP	O
,	,	,	O	O
ALFONZO	ALFONZO	NNP	B-NP	O
L.	L.	NNP	I-NP	O
,	,	,	O	O
M.D.	M.D.	NNP	B-NP	O
SERIOUS	SERIOUS	NNP	I-NP	O
INTERACTION	INTERACTION	NNP	I-NP	O
:	:	:	O	O
HEPARIN	HEPARIN	NNP	B-NP	O
&	&	CC	I-NP	O
ENOXAPARIN	ENOXAPARIN	NNP	I-NP	O
SODIUM	SODIUM	NNP	I-NP	O
Reason	Reason	NNP	I-NP	O
for	for	IN	B-PP	O
override	override	NN	B-NP	O
:	:	:	O	O
AWARE	AWARE	NN	B-NP	O
ATENOLOL	ATENOLOL	NN	I-NP	O
25	25	CD	B-NP	O
MG	MG	NNP	I-NP	O
PO	PO	NNP	I-NP	O
QD	QD	NNP	I-NP	O
Food/Drug	Food/Drug	NNP	I-NP	O
Interaction	Interaction	NNP	I-NP	O
Instruction	Instruction	NNP	I-NP	O
Take	Take	NNP	I-NP	O
consistently	consistently	RB	B-ADVP	O
with	with	IN	B-PP	O
meals	meal	NNS	B-NP	O
or	or	CC	B-PP	O
on	on	IN	B-PP	O
empty	empty	JJ	B-NP	O
stomach	stomach	NN	I-NP	O
.	.	.	O	O

DIET	DIET	NN	B-NP	O
:	:	:	O	O
No	No	DT	B-NP	O
Restrictions	Restriction	NNS	I-NP	O
RETURN	RETURN	NNP	B-NP	O
TO	TO	NNP	I-NP	O
WORK	WORK	NNP	I-NP	O
:	:	:	O	O
Not	Not	NNP	B-NP	O
Applicable	Applicable	NNP	I-NP	O
FOLLOW	FOLLOW	NNP	I-NP	O
UP	UP	NNP	I-NP	O
APPOINTMENT	APPOINTMENT	NNP	I-NP	O
-LRB-	-LRB-	NNP	I-NP	O
S	S	NNP	I-NP	O
-RRB-	-RRB-	NNP	I-NP	O
:	:	:	O	O
Dr.	Dr.	NNP	B-NP	O
Coy	Coy	NNP	I-NP	O
Simpler	Simpler	NNP	I-NP	O
1-2	1-2	NN	I-NP	O
weeks	week	NNS	I-NP	O
,	,	,	O	O
Dr.	Dr.	NNP	B-NP	O
Gabriel	Gabriel	NNP	I-NP	O
Bierle	Bierle	NNP	I-NP	O
4-6	4-6	NN	I-NP	O
weeks	week	NNS	I-NP	O
,	,	,	O	O
Dr.	Dr.	NNP	B-NP	O
Dusty	Dusty	NNP	I-NP	O
Sumida	Sumida	NNP	I-NP	O
1	1	CD	I-NP	O
month	month	NN	I-NP	O
,	,	,	O	O
No	No	NNP	B-NP	O
Known	Known	NNP	I-NP	O
Allergies	Allergies	NNP	I-NP	O
ADMIT	ADMIT	NNP	I-NP	O
DIAGNOSIS	DIAGNOSIS	NNP	I-NP	O
:	:	:	O	O
afib	afib	JJ	B-NP	O
c	c	NN	I-NP	O
RVR	RVR	NN	I-NP	O
PRINCIPAL	PRINCIPAL	JJ	I-NP	O
DISCHARGE	DISCHARGE	NN	I-NP	O
DIAGNOSIS	DIAGNOSIS	NN	I-NP	O
;	;	:	O	O
Responsible	Responsible	JJ	B-ADJP	O
After	After	IN	B-PP	O
Study	Study	NNP	B-NP	O
for	for	IN	B-PP	O
Causing	Causing	NNP	B-NP	O
Admission	Admission	NNP	I-NP	O
-RRB-	-RRB-	NNP	I-NP	O
afib	afib	NN	I-NP	O
,	,	,	O	O
S/P	S/P	NN	B-NP	O
TIA	TIA	NN	I-NP	O
OTHER	OTHER	NN	I-NP	O
DIAGNOSIS	DIAGNOSIS	NN	I-NP	O
;	;	:	O	O
Conditions	Condition	NNS	B-NP	O
,	,	,	O	O
Infections	Infection	NNS	B-NP	O
,	,	,	O	O
Complications	Complication	NNS	B-NP	O
,	,	,	O	O
affecting	affect	VBG	B-VP	O
Treatment/Stay	Treatment/Stay	NNP	B-NP	O
HTN	HTN	NN	I-NP	O
,	,	,	O	O
depression	depression	NN	B-NP	O
,	,	,	O	O
h/o	h/o	NN	B-NP	O
positive	positive	JJ	I-NP	O
PPD	PPD	NN	I-NP	O
,	,	,	O	O
recv	recv	NN	B-NP	O
'd	'd	MD	B-VP	O
INH	INH	NN	B-NP	O
,	,	,	O	O
h/o	h/o	NN	B-NP	O
substance	substance	NN	I-NP	O
abuse	abuse	NN	I-NP	O
-LRB-	-LRB-	NN	I-NP	O
cocaine	cocaine	NN	I-NP	O
-RRB-	-RRB-	NN	I-NP	O
OPERATIONS	OPERATIONS	NNS	I-NP	O
AND	AND	CC	I-NP	O
PROCEDURES	PROCEDURES	NNS	I-NP	O
:	:	:	O	O
OTHER	OTHER	NN	B-NP	O
TREATMENTS/PROCEDURES	TREATMENTS/PROCEDURES	VBZ	B-VP	O
-LRB-	-LRB-	NNP	B-NP	O
NOT	NOT	NNP	I-NP	O
IN	IN	NNP	I-NP	O
O.R.	O.R.	NNP	I-NP	O
-RRB-	-RRB-	NNP	I-NP	O
none	none	NN	I-NP	O
BRIEF	BRIEF	NN	I-NP	O
RESUME	RESUME	NN	I-NP	O
OF	OF	IN	B-PP	O
HOSPITAL	HOSPITAL	JJ	B-NP	O
COURSE	COURSE	NN	I-NP	O
:	:	:	O	O
47	47	CD	B-NP	O
y/o	y/o	NN	I-NP	O
female	female	JJ	I-NP	O
c	c	NN	I-NP	O
h/o	h/o	NN	I-NP	O
HTN	HTN	NN	I-NP	O
,	,	,	O	O
depression	depression	NN	B-NP	O
,	,	,	O	O
substance	substance	NN	B-NP	O
abuse	abuse	NN	I-NP	O
,	,	,	O	O
presented	present	VBN	B-VP	O
to	to	TO	B-VP	O
ED	ED	VBN	I-VP	O
on	on	IN	B-PP	O
2/2/01	2/2/01	CD	B-NP	O
c	c	NN	I-NP	O
complaints	complaint	NNS	I-NP	O
of	of	IN	B-PP	O
rapid	rapid	JJ	B-NP	O
heart	heart	NN	I-NP	O
beat	beat	NN	I-NP	O
,	,	,	O	O
palpitations	palpitation	NNS	B-NP	O
,	,	,	O	O
and	and	CC	O	O
chest	ch	JJS	B-NP	O
heaviness/pain	heaviness/pain	NN	I-NP	O
radiating	radiate	VBG	B-VP	O
to	to	TO	B-PP	O
left	left	JJ	B-NP	O
arm	arm	NN	I-NP	O
.	.	.	O	O

Symptoms	Symptom	NNS	B-NP	O
progressed	progress	VBD	B-VP	O
to	to	TO	B-PP	O
left-sided	left-sided	JJ	B-NP	O
weakness	weakness	NN	I-NP	O
/	/	SYM	B-NP	O
heaviness	heaviness	NN	I-NP	O
and	and	CC	O	O
sensory	sensory	JJ	B-NP	O
loss	loss	NN	I-NP	O
.	.	.	O	O

In	In	IN	B-PP	O
ED	ED	NN	B-NP	O
,	,	,	O	O
pt	pt	NN	B-NP	O
.	.	.	O	O

found	find	VBN	B-VP	O
to	to	TO	I-VP	O
be	be	VB	I-VP	O
in	in	IN	B-PP	O
afib	afib	JJ	B-NP	O
c	c	NN	I-NP	O
RVR	RVR	NN	I-NP	O
,	,	,	O	O
rate	rate	NN	B-NP	B-protein
controlled	controlled	JJ	I-NP	I-protein
c	c	NN	I-NP	I-protein
Diltiazem	Diltiazem	NN	I-NP	I-protein
IV	IV	CD	I-NP	I-protein
.	.	.	O	O

CT/CTA	CT/CTA	NN	B-NP	B-protein
showed	show	VBD	B-VP	O
question	question	NN	B-NP	O
of	of	IN	B-PP	O
a	a	DT	B-NP	O
clot	clot	NN	I-NP	O
in	in	IN	B-PP	O
M2	M2	NN	B-NP	B-cell_line
vessel	vessel	NN	I-NP	I-cell_line
,	,	,	O	O
therefore	therefore	RB	B-ADVP	O
Heparinized	Heparinize	VBN	B-VP	O
and	and	CC	O	O
transferred	transfer	VBN	B-VP	O
to	to	TO	B-PP	O
Or	Or	NNP	B-NP	O
Van	Van	NNP	I-NP	O
Sa	Sa	NNP	I-NP	O
for	for	IN	B-PP	O
acute	acute	JJ	B-NP	O
stroke	stroke	NN	I-NP	O
care	care	NN	I-NP	O
.	.	.	O	O

TTE	TTE	NN	B-NP	O
showed	show	VBD	B-VP	O
LVH	LVH	NN	B-NP	B-protein
,	,	,	O	O
mild	mild	JJ	B-NP	O
LAE	LAE	NN	I-NP	O
,	,	,	O	O
no	no	DT	B-NP	O
thrombus	thrombus	NN	I-NP	O
.	.	.	O	O

EKG	EKG	NN	B-NP	B-protein
's	's	POS	B-NP	I-protein
c	c	NN	I-NP	I-protein
afib	afib	NN	I-NP	I-protein
,	,	,	O	O
LVH	LVH	NN	B-NP	B-protein
,	,	,	O	O
ST/T	ST/T	NN	B-NP	O
wave	wave	NN	I-NP	O
changes	change	NNS	I-NP	O
c/w	c/w	VBP	B-VP	O
strain	strain	NN	B-NP	O
pattern	pattern	NN	I-NP	O
.	.	.	O	O

CPK	CPK	NN	B-NP	B-protein
's	's	POS	B-NP	O
,	,	,	O	O
troponin	troponin	NN	B-NP	O
flat	flat	JJ	B-ADJP	O
.	.	.	O	O

MRI	MRI	NN	B-NP	B-protein
showed	show	VBD	B-VP	O
very	very	RB	B-NP	O
small	small	JJ	I-NP	O
white	white	JJ	I-NP	O
matter	matter	NN	I-NP	O
changes	change	NNS	I-NP	O
in	in	IN	B-PP	O
right	right	JJ	B-NP	O
hemisphere	hemisphere	NN	I-NP	O
not	not	RB	O	O
felt	feel	VBD	B-VP	O
to	to	TO	I-VP	O
be	be	VB	I-VP	O
clinically	clinically	RB	B-ADJP	O
significant	significant	JJ	I-ADJP	O
-LRB-	-LRB-	HYPH	O	O
no	no	DT	B-NP	O
evidence	evidence	NN	I-NP	O
for	for	IN	B-PP	O
acute	acute	JJ	B-NP	O
stroke	stroke	NN	I-NP	O
-RRB-	-RRB-	NN	I-NP	O
.	.	.	O	O

Neurologic	Neurologic	JJ	B-NP	O
defecitcharacterized	defecitcharacterize	VBN	B-VP	O
by	by	IN	B-PP	O
left	left	JJ	B-NP	O
hemiparesis	hemiparesis	NN	I-NP	O
and	and	CC	I-NP	O
hemianopsia	hemianopsia	NN	I-NP	O
in	in	IN	B-PP	O
ED	ED	NNP	B-NP	O
,	,	,	O	O
over	over	IN	B-PP	O
time	time	NN	B-NP	O
evolved	evolve	VBN	B-VP	O
into	into	IN	B-PP	O
left	left	JJ	B-NP	O
eye	eye	NN	I-NP	O
blurriness/decreased	blurriness/decrease	VBD	B-VP	O
vision	vision	NN	B-NP	O
,	,	,	O	O
left	leave	VBD	B-VP	O
facial	facial	JJ	B-NP	O
numbness	numbness	NN	I-NP	O
-LRB-	-LRB-	HYPH	B-VP	O
no	no	DT	B-NP	O
droop	droop	NN	I-NP	O
-RRB-	-RRB-	NN	I-NP	O
,	,	,	O	O
right	right	JJ	B-NP	O
arm	arm	NN	I-NP	O
and	and	CC	I-NP	O
leg	leg	NN	I-NP	O
numbness	numbness	NN	I-NP	O
and	and	CC	O	O
weakness	weakness	NN	B-NP	O
.	.	.	O	O

Above	Above	IN	B-PP	O
exam	exam	NN	B-NP	O
felt	feel	VBD	B-VP	O
to	to	TO	I-VP	O
be	be	VB	I-VP	O
inconsistent	inconsistent	JJ	B-ADJP	O
with	with	IN	B-PP	O
single	single	JJ	B-NP	O
lesion	lesion	NN	I-NP	O
,	,	,	O	O
opinion	opinion	NN	B-NP	O
of	of	IN	B-PP	O
psych	psych	NN	B-NP	O
and	and	CC	I-NP	O
neurology	neurology	NN	I-NP	O
was	be	VBD	B-VP	O
that	that	IN	B-SBAR	O
the	the	DT	B-NP	O
above	above	JJ	I-NP	O
symptoms	symptom	NNS	I-NP	O
represented	represent	VBD	B-VP	O
psychogenic	psychogenic	JJ	B-NP	O
augmentation	augmentation	NN	I-NP	O
of	of	IN	B-PP	O
an	an	DT	B-NP	O
initial	initial	JJ	I-NP	O
real	real	JJ	I-NP	O
neuro	neuro	NN	I-NP	O
defecit	defecit	NN	I-NP	O
from	from	IN	B-PP	O
TIA/small	TIA/small	JJ	B-NP	O
embolic	embolic	JJ	I-NP	O
stroke	stroke	NN	I-NP	O
which	which	WDT	B-NP	O
recanalized	recanalize	VBD	B-VP	O
.	.	.	O	O

Transferred	Transfer	VBN	B-VP	O
to	to	TO	B-PP	O
floor	floor	NN	B-NP	O
on	on	IN	B-PP	O
9/21/01	9/21/01	CD	B-NP	O
in	in	IN	B-PP	O
afib	afib	NN	B-NP	O
c	c	NN	I-NP	O
rate	rate	NN	I-NP	O
in	in	IN	B-PP	O
90	90	CD	B-NP	O
's	's	POS	B-NP	O
on	on	IN	B-PP	O
Digoxin	Digoxin	NN	B-NP	O
and	and	CC	I-NP	O
Lopressor	Lopressor	NN	I-NP	O
.	.	.	O	O

Started	Start	VBN	B-VP	O
on	on	IN	B-PP	O
Coumadin	Coumadin	NN	B-NP	O
that	that	IN	B-NP	O
night	night	NN	B-NP	O
,	,	,	O	O
Heparin	Heparin	NN	B-NP	O
continued	continue	VBD	B-VP	O
at	at	IN	B-PP	O
therapeutic	therapeutic	JJ	B-NP	O
range	range	NN	I-NP	O
until	until	IN	B-PP	O
initiation	initiation	NN	B-NP	O
of	of	IN	B-PP	O
Lovenox	Lovenox	NN	B-NP	O
on	on	IN	B-PP	O
hosp	hosp	NN	B-NP	O
.	.	.	O	O

day	day	NN	B-NP	O
#	#	#	B-NP	O
6	6	CD	I-NP	O
.	.	.	O	O

Spontaneously	Spontaneously	RB	B-ADVP	O
converted	convert	VBN	B-VP	O
to	to	TO	B-PP	O
NSR	NSR	NN	B-NP	B-protein
on	on	IN	B-PP	O
Lopressor	Lopressor	NN	B-NP	O
100	100	CD	I-NP	O
mg	mg	NN	I-NP	O
PO	PO	NN	I-NP	O
tid	tid	NN	I-NP	O
on	on	IN	B-PP	O
3/18/01	3/18/01	CD	B-NP	O
,	,	,	O	O
Lopressor	Lopressor	NNP	B-NP	O
decreased	decrease	VBD	B-VP	O
to	to	TO	B-PP	O
50	50	CD	B-NP	O
po	po	NN	I-NP	O
tid	tid	NN	I-NP	O
secondary	secondary	JJ	B-ADJP	O
to	to	TO	B-PP	O
sinus	sinus	NN	B-NP	O
bradycardia	bradycardia	NN	I-NP	O
,	,	,	O	O
then	then	RB	B-ADVP	O
converted	convert	VBD	B-VP	O
to	to	TO	I-VP	O
Atenolol	Atenolol	VB	I-VP	O
25	25	CD	B-NP	O
mg	mg	NN	I-NP	O
PO	PO	NN	I-NP	O
qd	qd	NN	I-NP	O
for	for	IN	B-PP	O
once	once	RB	B-NP	O
daily	daily	JJ	I-NP	O
dosing	dosing	NN	I-NP	O
.	.	.	O	O

Neurologic	Neurologic	JJ	B-NP	O
deficit	deficit	NN	I-NP	O
spontaneously	spontaneously	RB	B-VP	O
resolved	resolve	VBD	I-VP	O
overnight	overnight	RB	B-ADVP	O
on	on	IN	B-PP	O
3/18/01	3/18/01	CD	B-NP	O
.	.	.	O	O

On	On	IN	B-PP	O
exam	exam	NN	B-NP	O
,	,	,	O	O
only	only	RB	B-NP	O
subtle	subtle	JJ	I-NP	O
weakness	weakness	NN	I-NP	O
detected	detect	VBN	B-VP	O
on	on	IN	B-PP	O
left	left	JJ	B-NP	O
arm	arm	NN	I-NP	O
and	and	CC	I-NP	O
finger	finger	NN	I-NP	O
extention	extention	NN	I-NP	O
,	,	,	O	O
numbness	numbness	NN	B-NP	O
completely	completely	RB	B-VP	O
resolved	resolve	VBN	I-VP	O
.	.	.	O	O

Patient	Patient	NN	B-NP	O
will	will	MD	B-VP	O
be	be	VB	I-VP	O
discharged	discharge	VBN	I-VP	O
to	to	TO	B-PP	O
home	home	NN	B-NP	O
in	in	IN	B-PP	O
stable	stable	JJ	B-NP	O
condition	condition	NN	I-NP	O
with	with	IN	B-PP	O
instructions	instruction	NNS	B-NP	O
to	to	TO	B-VP	O
follow	follow	VB	I-VP	O
up	up	RP	B-PRT	O
with	with	IN	B-PP	O
PCP	PCP	NN	B-NP	B-protein
in	in	IN	B-PP	O
1-2	1-2	CD	B-NP	O
weeks	week	NNS	I-NP	O
and	and	CC	B-PP	O
with	with	IN	B-PP	O
Dr.	Dr.	NNP	B-NP	O
Lapine	Lapine	NNP	I-NP	O
in	in	IN	B-PP	O
4-6	4-6	CD	B-NP	O
weeks	week	NNS	I-NP	O
.	.	.	O	O

Coumadin	Coumadin	NN	B-NP	O
titration	titration	NN	I-NP	O
will	will	MD	B-VP	O
be	be	VB	I-VP	O
carried	carry	VBN	I-VP	O
out	out	RP	B-PRT	O
by	by	IN	B-PP	O
INMC	INMC	NNP	B-NP	O
Fort	Fort	NNP	I-NP	O
A	A	NNP	I-NP	O
Sas	Sas	NNP	I-NP	O
office	office	NN	I-NP	O
.	.	.	O	O

VNA	VNA	NN	B-NP	O
sercices	sercice	NNS	I-NP	O
will	will	MD	B-VP	O
carry	carry	VB	I-VP	O
out	out	RP	B-PRT	O
Lovenox	Lovenox	NNP	B-NP	O
administration/education	administration/education	NN	I-NP	O
.	.	.	O	O

Plan	Plan	NN	B-NP	O
is	be	VBZ	B-VP	O
for	for	IN	B-PP	O
4-6	4-6	CD	B-NP	O
weeks	week	NNS	I-NP	O
of	of	IN	B-PP	O
therapeutic	therapeutic	JJ	B-NP	O
anticoagulation	anticoagulation	NN	I-NP	O
on	on	IN	B-PP	O
Coumadin	Coumadin	NN	B-NP	O
,	,	,	O	O
then	then	RB	B-ADVP	O
reassess	reassess	NN	B-NP	O
need	need	VBP	B-VP	O
if	if	IN	B-SBAR	O
still	still	RB	B-ADVP	O
in	in	IN	B-PP	O
NSR	NSR	NN	B-NP	B-protein
.	.	.	O	O

ADDITIONAL	ADDITIONAL	JJ	B-NP	O
COMMENTS	COMMENTS	NNS	I-NP	O
:	:	:	O	O
You	You	PRP	B-NP	B-protein
should	should	MD	B-VP	O
call	call	VB	I-VP	O
Dr.	Dr.	NNP	B-NP	O
Sphon	Sphon	NNP	I-NP	O
office	office	NN	I-NP	O
tomorrow	tomorrow	NN	I-NP	O
morning	morning	NN	I-NP	O
for	for	IN	B-PP	O
an	an	DT	B-NP	O
appt	appt	NN	I-NP	O
.	.	.	O	O

this	this	DT	B-NP	O
week	week	NN	I-NP	O
.	.	.	O	O

You	You	PRP	B-NP	B-protein
will	will	MD	B-VP	O
have	have	VB	I-VP	O
VNA	VNA	NN	B-NP	B-protein
come	come	VBN	B-VP	O
to	to	TO	B-PP	O
your	your	PRP$	B-NP	O
home	home	NN	I-NP	O
this	this	DT	B-NP	O
evening	evening	NN	I-NP	O
for	for	IN	B-PP	O
Lovenox	Lovenox	NN	B-NP	O
shot	shot	NN	I-NP	O
administration/education	administration/education	NN	I-NP	O
.	.	.	O	O

You	You	PRP	B-NP	B-protein
should	should	MD	B-VP	O
take	take	VB	I-VP	O
Coumadin	Coumadin	NNP	B-NP	O
as	as	RB	B-ADVP	O
well	well	RB	I-ADVP	O
for	for	IN	B-PP	O
the	the	DT	B-NP	O
next	next	JJ	I-NP	O
month	month	NN	I-NP	O
as	as	IN	B-SBAR	O
directed	direct	VBN	B-VP	O
by	by	IN	B-PP	O
your	your	PRP$	B-NP	O
doctor	doctor	NN	I-NP	O
.	.	.	O	O

You	You	PRP	B-NP	B-protein
will	will	MD	B-VP	O
need	need	VB	I-VP	O
to	to	TO	I-VP	O
have	have	VB	I-VP	O
blood	blood	NN	B-NP	O
drawn	draw	VBN	B-VP	O
through	through	IN	B-PP	O
the	the	DT	B-NP	O
PH	PH	NNP	I-NP	O
Sey	Sey	NNP	I-NP	O
Ni	Ni	NNP	I-NP	O
Mont	Mont	NNP	I-NP	O
office	office	NN	I-NP	O
for	for	IN	B-PP	O
INR	INR	NN	B-NP	B-protein
levels	level	NNS	I-NP	O
starting	start	VBG	B-PP	O
tomorrow	tomorrow	NN	B-NP	O
.	.	.	O	O

Call	Call	VB	B-VP	O
your	your	PRP$	B-NP	O
doctor	doctor	NN	I-NP	O
or	or	CC	O	O
return	return	VB	B-VP	O
to	to	TO	B-PP	O
the	the	DT	B-NP	O
ED	ED	NNP	I-NP	O
if	if	IN	B-SBAR	O
you	you	PRP	B-NP	O
have	have	VBP	B-VP	O
chest	chest	NN	B-NP	O
pain	pain	NN	I-NP	O
,	,	,	O	O
palpitations	palpitation	NNS	B-NP	O
,	,	,	O	O
lightheadedness	lightheadedness	NN	B-NP	O
,	,	,	O	O
weakness	weakness	NN	B-NP	O
,	,	,	O	O
or	or	CC	O	O
other	other	JJ	B-NP	O
worrisome	worrisome	JJ	I-NP	O
symptoms	symptom	NNS	I-NP	O
.	.	.	O	O

DISCHARGE	DISCHARGE	NN	B-NP	O
CONDITION	CONDITION	NN	I-NP	O
:	:	:	O	O
Stable	Stable	JJ	B-NP	O
TO	TO	NN	I-NP	O
DO/PLAN	DO/PLAN	NN	I-NP	O
:	:	:	O	O
No	No	DT	B-NP	O
dictated	dictated	JJ	I-NP	O
summary	summary	NN	I-NP	O
ENTERED	ENTERED	NNP	I-NP	O
BY	BY	NNP	I-NP	O
:	:	:	O	O
DONOGHUE	DONOGHUE	NNP	B-NP	O
,	,	,	O	O
DAMIEN	DAMIEN	NNP	B-NP	O
J.	J.	NNP	I-NP	O
,	,	,	O	O
M.D.	M.D.	NNP	B-NP	O
-LRB-	-LRB-	NNP	I-NP	O
EC82	EC82	NNP	I-NP	O
-RRB-	-RRB-	NNP	I-NP	O
6/5/01	6/5/01	CD	I-NP	O
@	@	NN	I-NP	O
02	02	CD	I-NP	O
:	:	:	O	O
00	00	CD	B-NP	O
PM	PM	NN	I-NP	O
******	******	SYM	B-NP	O
END	END	NN	I-NP	O
OF	OF	IN	B-PP	O
DISCHARGE	DISCHARGE	NN	B-NP	O
ORDERS	ORDERS	NNS	I-NP	O
******	******	SYM	B-NP	O

